Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sayan, A"'
Autor:
Sayan, Murat, Yıldırım, Figen Sarıgül, Akhan, Sıla, Yıldırım, Arzu Altunçekiç, Şirin, Göktuğ, Cabalak, Mehmet, Demir, Mehmet, Can, Selver, Ersöz, Gülden, Altıntaş, Engin, Ensaroğlu, Fatih, Akbulut, Ayhan, Şener, Alper, Deveci, Aydın
Publikováno v:
In International Journal of Infectious Diseases June 2020 95:84-89
Autor:
Murat Sayan, Figen Sarıgül Yıldırım, Sıla Akhan, Arzu Altunçekiç Yıldırım, Göktuğ Şirin, Mehmet Cabalak, Mehmet Demir, Selver Can, Gülden Ersöz, Engin Altıntaş, Fatih Ensaroğlu, Ayhan Akbulut, Alper Şener, Aydın Deveci
Publikováno v:
International Journal of Infectious Diseases, Vol 95, Iss , Pp 84-89 (2020)
Objectives: Chronic hepatitis C (CHC) is now a more curable disease with new direct acting antivirals (DAA). Although high sustained virologic response rates, failures still occur in DAA regimens. Our objective in this study was to characterize the r
Externí odkaz:
https://doaj.org/article/d97a9628004347cbb125835895076b62
Autor:
Elif Sargin Altunok, Murat Sayan, Sila Akhan, Bilgehan Aygen, Orhan Yildiz, Suda Tekin Koruk, Resit Mistik, Nese Demirturk, Onur Ural, Şükran Kose, Aynur Aynioglu, Fatime Korkmaz, Gülden Ersoz, Nazan Tuna, Celal Ayaz, Faruk Karakecili, Derya Keten, Dilara Inan, Saadet Yazici, Safiye Koculu, Taner Yildirmak
Publikováno v:
International Journal of Infectious Diseases, Vol 50, Iss C, Pp 1-5 (2016)
Background: Drug resistance development is an expected problem during treatment with protease inhibitors (PIs), this is largely due to the fact that Pls are low-genetic barrier drugs. Resistance-associated variants (RAVs) however may also occur natur
Externí odkaz:
https://doaj.org/article/746674f3f2674d80aa0bd064e45cced1
Autor:
Alper Şener, Engin Altintaş, Gülden Ersöz, Selver Can, Mehmet Gökhan Demir, Sıla Akhan, Figen Sarigul Yildirim, Murat Sayan, Mehmet Çabalak, Fatih Ensaroğlu, Göktuğ Şirin, Ayhan Akbulut, Aydın Deveci, Arzu Altunçekiç Yıldırım
Publikováno v:
International Journal of Infectious Diseases, Vol 95, Iss, Pp 84-89 (2020)
Objectives: Chronic hepatitis C (CHC) is now a more curable disease with new direct acting antivirals (DAA). Although high sustained virologic response rates, failures still occur in DAA regimens. Our objective in this study was to characterize the r
Autor:
Sayan, M., Akhan, S.C.
Publikováno v:
In International Journal of Infectious Diseases 2011 15(10):e722-e726
Publikováno v:
In International Journal of Infectious Diseases September 2010 14 Supplement 3:e136-e141
Autor:
Aynur Aynioglu, Gülden Ersöz, Dilara Inan, Sıla Akhan, Sukran Kose, Saadet Yazici, Suda Tekin Koruk, Celal Ayaz, Onur Ural, Reşit Mistik, Bilgehan Aygen, Nazan Tuna, Safiye Koculu, Fatime Korkmaz, Murat Sayan, Neşe Demirtürk, Faruk Karakeçili, Taner Yildirmak, Elif Sargin Altunok, Derya Keten, Orhan Yildiz
Publikováno v:
International Journal of Infectious Diseases, Vol 50, Iss C, Pp 1-5 (2016)
WOS: 000388326300001
PubMed: 27401586
Background: Drug resistance development is an expected problem during treatment with protease inhibitors (PIs), this is largely due to the fact that Pls are low-genetic barrier drugs. Resistance-associa
PubMed: 27401586
Background: Drug resistance development is an expected problem during treatment with protease inhibitors (PIs), this is largely due to the fact that Pls are low-genetic barrier drugs. Resistance-associa
Publikováno v:
International Journal of Infectious Diseases, Vol 21, Iss S1, p 459 (2014)
Externí odkaz:
https://doaj.org/article/fa02707e78a54fff90523ab4328bd5b6
Publikováno v:
International Journal of Infectious Diseases, Vol 21, Iss S1, p 456 (2014)
Externí odkaz:
https://doaj.org/article/7740c79b03ae4d6c8e94797d6087e902
Publikováno v:
International Journal of Infectious Diseases. 14:e136-e141
Summary Background The hepatitis B virus (HBV) polymerase gene completely overlaps with the envelope gene. In the present study we aimed to monitor the prevalence and pattern of the typical mutations for hepatitis B surface antigen (HBsAg) escape, an